檢索結果 - Mabel Ryder

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond

    Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond 由 Maria E. Cabanillas, Mabel Ryder, Camilo Jiménez

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients

    PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients 由 Anupam Kotwal, Lisa A. Kottschade, Mabel Ryder

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution

    Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution 由 Mabel Ryder, Margaret K. Callahan, Michael A. Postow, Jedd D. Wolchok, James A. Fagin

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells

    Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells 由 Matti L. Gild, Iñigo Landa, Mabel Ryder, Ronald Ghossein, Jeffrey A. Knauf, James A. Fagin

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer

    Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer 由 Anupam Kotwal, Michael P. Gustafson, Svetlana Bornschlegl, Allan B. Dietz, Danae A. Delivanis, Mabel Ryder

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations

    Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations 由 Anupam Kotwal, Michael P. Gustafson, Svetlana Bornschlegl, Lisa A. Kottschade, Danae A. Delivanis, Allan B. Dietz, Manish J. Gandhi, Mabel Ryder

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression

    Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression 由 Mabel Ryder, Matti L. Gild, Tobias M. Hohl, Eric G. Pamer, Jeffrey A. Knauf, Ronald Ghossein, Johanna A. Joyce, James A. Fagin

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

    Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms 由 Danae A. Delivanis, Michael P. Gustafson, Svetlana Bornschlegl, Michele M. Merten, Lisa A. Kottschade, Sarah G. Withers, Allan B. Dietz, Mabel Ryder

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas

    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas 由 Cristina Montero‐Conde, Sergio Ruiz‐Llorente, José Miguel Domínguez, Jeffrey A. Knauf, Agnès Viale, Eric J. Sherman, Mabel Ryder, Ronald Ghossein, Neal Rosen, James A. Fagin

    出版 2013
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  10. 10
    Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for<i>BRAF, PIK3CA</i>, and<i>AKT1</i>

    Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for<i>BRAF, PIK3CA</i>, and<i>AKT1</i> 由 Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David B. Solit, Jeffrey A. Knauf, R. Michael Tuttle, Ronald Ghossein, James A. Fagin

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

    Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study 由 Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith, Sarah M. Jenkins, Robert L. Foote, Jan L. Kasperbauer, John C. Morris, Mabel Ryder, Samer Alsidawi, Crystal Hilger, Keith C. Bible

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy 由 Laura Boucai, Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mabel Ryder, Alan L. Ho, Ronald Ghossein, Luc G.T. Morris, Venkatraman Seshan, James A. Fagin

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

    Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation 由 Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A. Knauf, Xiao-Hui Liao, Brian L. West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M. Larson, Samuel Refetoff, Ronald Ghossein, James A. Fagin

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

    Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma 由 Sara Bedrose, Kevin C. Miller, Lina Altameemi, M. Shaaban Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D. Eaton, Jeffrey T. Yorio, Davey B. Daniel, Matthew T. Campbell, Keith C. Bible, Mabel Ryder, Ashish V. Chintakuntlawar, Mouhammed Amir Habra

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

    Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer 由 Naiyarat Prasongsook, Aditi Kumar, Ashish V. Chintakuntlawar, Robert L. Foote, Jan L. Kasperbauer, Julian R. Molina, Yolanda I. Garces, J. Daniel, Michelle A. Neben Wittich, Joseph Rubin, Ronald L. Richardson, John H. Morris, Ian Hay, Vahab Fatourechi, Bryan McIver, Mabel Ryder, Geoffrey B. Thompson, Clive S. Grant, Melanie L. Richards, Thomas J. Sebo, Michael Rivera, Vera J. Suman, Sarah M. Jenkins, Robert C. Smallridge, Keith C. Bible

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

    Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology 由 John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

    NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 由 John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Benjamin H. Kaffenberger, Matthew A. Lunning, Suzanne McGettigan, Jordan P. McPherson, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Nathan A. Pennell, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Ryan Weight, Alyse Johnson-Chilla, Griselda Zuccarino-Catania, Anita M. Engh

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment

    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thy... 由 David C. Shonka, Alan L. Ho, Ashish V. Chintakuntlawar, J.L. Geiger, Jong Chul Park, Nagashree Seetharamu, Sina Jasim, Amr H. Abdelhamid Ahmed, Keith C. Bible, Marcia S. Brose, Maria E. Cabanillas, Kirsten F. A. A. Dabekaussen, Louise Davies, Dora Dias‐Santagata, James A. Fagin, William C. Faquin, Ronald Ghossein, Raj K. Gopal, Akira Miyauchi, Yuri E. Nikiforov, Matthew D. Ringel, Bruce Robinson, Mabel Ryder, Eric J. Sherman, Peter M. Sadow, Jennifer J. Shin, Brendan C. Stack, R. Michael Tuttle, Lori J. Wirth, Mark Zafereo, Gregory W. Randolph

    出版 2022
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

    Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology 由 John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Amaka Achufusi, Philippe Armand, Meghan Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael D. Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa S. Marr, Suzanne McGettigan, Jordan P. McPherson, Theresa Medina, Nisha Mohindra, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Pradnya D. Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary A. Dwyer, Lisa Hang

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: